Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Anis A. Hamid"'
Publikováno v:
Current Oncology, Vol 30, Iss 1, Pp 923-937 (2023)
Non-clear cell renal cell carcinoma (nccRCC) is an entity comprised of a heterogeneous constellation of RCC subtypes. Genomic profiling has broadened our understanding of molecular pathogenic mechanisms unique to individual nccRCC subtypes. To date,
Externí odkaz:
https://doaj.org/article/06996fc28c7a405fb83e1c27e2405ae8
Autor:
Emily Grist, Stefanie Friedrich, Christopher Brawley, Larissa Mendes, Marina Parry, Adnan Ali, Aine Haran, Alex Hoyle, Claire Gilson, Sharanpreet Lall, Leila Zakka, Carla Bautista, Alex Landless, Karolina Nowakowska, Anna Wingate, Daniel Wetterskog, A. M. Mahedi Hasan, Nafisah B. Akato, Malissa Richmond, Sofeya Ishaq, Nik Matthews, Anis A. Hamid, Christopher J. Sweeney, Matthew R. Sydes, Daniel M. Berney, Stefano Lise, STAMPEDE investigators, Mahesh K. B. Parmar, Noel W. Clarke, Nicholas D. James, Paolo Cremaschi, Louise C. Brown, Gerhardt Attard
Publikováno v:
Genome Medicine, Vol 14, Iss 1, Pp 1-15 (2022)
Abstract Background Genomic copy number alterations commonly occur in prostate cancer and are one measure of genomic instability. The clinical implication of copy number change in advanced prostate cancer, which defines a wide spectrum of disease fro
Externí odkaz:
https://doaj.org/article/506e0f56118040028d430cc8873797f0
Autor:
Ben Tran, Jose M. Ruiz‐Morales, Enrique Gonzalez‐Billalabeitia, Anna Patrikidou, Eitan Amir, Christoph Seidel, Carsten Bokemeyer, Christian Fankhauser, Thomas Hermanns, Alexey Rumyantsev, Alexey Tryakin, Margarida Brito, Aude Fléchon, Edmond Michael Kwan, Tina Cheng, Daniel Castellano, Xavier Garcia del Muro, Anis A. Hamid, Margaret Ottaviano, Giovannella Palmieri, Robert Kitson, Alison Reid, Daniel Y. C. Heng, Philippe L. Bedard
Publikováno v:
Cancer Medicine, Vol 9, Iss 1, Pp 116-124 (2020)
Abstract Background Metastatic germ cell tumor (mGCT) patients receiving chemotherapy have increased risk of life‐threatening venous thromboembolism (VTE). Identifying VTE risk factors may guide thromboprophylaxis in this highly curable population.
Externí odkaz:
https://doaj.org/article/2123242758fc44e884e8dd8dcda39929
Autor:
Anis A. Hamid, Nicolas Sayegh, Bertrand Tombal, Maha Hussain, Christopher J. Sweeney, Julie N. Graff, Neeraj Agarwal
Publikováno v:
American Society of Clinical Oncology Educational Book.
The advent of more effective treatment combinations for metastatic hormone-sensitive prostate cancer (mHSPC) has been built on successes in therapy development for metastatic, castration-resistant prostate cancer (mCRPC). Both disease phases hold sim
Autor:
Adam B. Weiner, Yang Liu, Alex Hakansson, Xin Zhao, James A. Proudfoot, Julian Ho, JJ H. Zhang, Eric V. Li, R. Jeffrey Karnes, Robert B. Den, Amar U. Kishan, Robert E. Reiter, Anis A. Hamid, Ashely E. Ross, Phuoc T. Tran, Elai Davicioni, Daniel E. Spratt, Gerhardt Attard, Tamara L. Lotan, Melvin Lee Kiang Chua, Christopher J. Sweeney, Edward M. Schaeffer
Publikováno v:
Cancer.
Autor:
Christopher J. Sweeney, Leigh Ellis, Nicole Pandell, John G. Clohessy, Anis A. Hamid, Katherine L. Morel
Representative images of cell death staining in 22Rv1 empty vector control and p65 overexpressing tumoroids treated +/- DMAPT and/or enzalutamide.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bec1657dd1a9924b4148ee131a75c09
https://doi.org/10.1158/1541-7786.22525907.v1
https://doi.org/10.1158/1541-7786.22525907.v1
Autor:
Christopher J. Sweeney, Leigh Ellis, Nicole Pandell, John G. Clohessy, Anis A. Hamid, Katherine L. Morel
NF-κB activation has been linked to prostate cancer progression and is commonly observed in castrate-resistant disease. It has been suggested that NF-κB–driven resistance to androgen-deprivation therapy (ADT) in prostate cancer cells may be media
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52560e6b3edf44ed385acd38e91808fa
https://doi.org/10.1158/1541-7786.c.6544955.v1
https://doi.org/10.1158/1541-7786.c.6544955.v1
Autor:
Amanda Pereira-Salgado, Shankar Siva, Anis A. Hamid, Koen Degeling, Niall M. Corcoran, Maarten Joost IJzerman
Publikováno v:
Value in Health. 24:1737-1745
Objectives To estimate the lifetime health and economic outcomes of selecting active surveillance (AS), radical prostatectomy (RP), or radiation therapy (RT) as initial management for low- or favorable-risk localized prostate cancer. Methods A discre
Autor:
Alexey Rumyantsev, Xavier Garcia del Muro, Edmon M. Kwan, Christian D. Fankhauser, Egon Gonzalez-Billalabeitia, Anis A. Hamid, Giovanella Palmieri, Alexey Tryakin, Philippe L. Bedard, Anna Patrikidou, Eitan Amir, Robert Kitson, Jean M. Connors, Carsten Bokemeyer, Tina Cheng, Ben Tran, Daniel Y.C. Heng, Jose Manuel Ruiz-Morales, Daniel Castellano, Christopher Sweeney, Aude Flechon, Thomas Hermanns, Manuel Pedregal, Margaret Ottaviano, Alison Reid, Christoph Seidel, Margarida Brito
Publikováno v:
European Urology Focus. 7:1130-1136
It remains unclear which patients with metastatic germ cell tumours (mGCTs) need prophylactic anticoagulation to prevent venous thromboembolic events (VTEs).To assess the risk and onset of VTEs stratified by risk factors.This multi-institutional retr